A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease

Clinical trial NCT00403494 · COMPLETED

Trial details

NCT number: NCT00403494
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intermittent Claudication

Start date: 2006-12-01
Primary completion: 2008-11-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.